D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BNGO holding history
Bionano Genomics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BNGO overviewAll 13F holders of BNGOFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −171,757−100.0% | Sold out | Holders |
| Q4 2023 | 171,757 | $324.6K | <0.1% | +171,757 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −279,116−100.0% | Sold out | Holders |
| Q3 2022 | 279,116 | $511.0K | <0.1% | +267,726+2,350.5% | Added | Holders |
| Q2 2022 | 11,390 | $16.0K | <0.1% | −408,316−97.3% | Reduced | Holders |
| Q1 2022 | 419,706 | $1.08M | <0.1% | +369,220+731.3% | Added | Holders |
| Q4 2021 | 50,486 | $151.0K | <0.1% | +50,486 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −11,096−100.0% | Sold out | Holders |
| Q2 2021 | 11,096 | $81.0K | <0.1% | +11,096 | New | Holders |